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Summary: Four different methods, using luminol-enhanced Chemiluminescence, are described for assessment
of the oxidative processes associated with the phagocytosis of opsonized zymosan by granulocytes. The tech-
niques described in the literature using whole blood äs a Substrate gave unreliable results due to quench
effects of contaminating red blood cells, unpredictable serum interferences, or varying ratios of granulocytes
and zymosan. In order to avoid these side effects, rapid and simple methods for the Isolation of the granulo-
cytes were applied, e.g. lysis of erythrocytes by ammonium Chloride, or the Isolation of granulocytes on a
percoll gradient. The latter procedure proved to be reliable, simple and sufficiently quick for a routine appli-
cation.
Vergleichende Untersuchungen von oxidativen Prozessen während der Phagocytose mittels Luminol-abhängi-
ger Chemilumineszenz
Zusammenfassung: In der vorliegenden Arbeit werden vier verschiedene Methoden zur Messung der oxida-
tiven Prozesse während der Phagocytose von Granülocyten unter Verwendung der Luminol-verstärkten Che-
milumineszenz beschrieben. Da mit den in der Literatur für Vollblut beschriebenen Verfahren wegen Quench-
effekten durch Erythjrocyten, unspezifischer Serumeffekte oder variabler Verhältnisse von Granülocyten zu
aufzunehmenden Partikeln keine befriedigenden Ergebnisse erhalten wurden, wurden schnelle und einfache
Verfahren der Isolierung von Granülocyten angewandt. Zum einen wurden die Erythrocyten im Vollblut
mittels Ammoniumchlorid lysiert, die andere Methode bediente sich der Isolierung reiner Granülocyten mit-
tels eines Percoll-Gradienten. Die letztere Methode erwies sich als zuverlässig, einfach und hinreichend
schnell für eine Anwendung in der Routine.
Introduction
Polymorphonuclear leukoeytes' are the organism's
first line of defense against many microorganisms.
The ability of neutrophilic granulocytes to adhere to
the surface of blood vessels, their diapedesis from
the blood stream into regions of inflammation, and
their properties of phagocytosis and killing of mi-
croorganisms are based upon a variety of highly
complex cellular reactions. Various functional dis-
orders of the gratiülocyte, both genetically deter-
mined and acquired, have been described in the li-
terature (1—5).
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The present study examines in detail the measur-
ment of Chemiluminescence äs an analytical tool for
assessing oxidative reactions during phagocytosis un-
der a variety of experimental conditions.
In 1972, Allen observed that neutrophilic granulo-
cytes emit photons during phagocytosis (6). The in-
teraction of granulocytes and other phagocytosing
cells with phagocytosable particles results in an acti-
vation of oxygen-dependent metabolic pathways
(respiratory burst, (7)); glucose turnover, in particu-
lar, is markedly increased via the hexose monophos-
phate shunt. As a result of the activation of a
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NADPH-oxidase, which is a membrane bound en-
zyme, Superoxide anion radicals are produced,
which, in turn, form highly reactive intermediates of
oxygen such s hydrogen peroxide, hypochloric acid,
hydroxyl radicals, and singlet oxygen (6, 8—12).
These reactive oxygen species can occur in an elec-
tronically excited state (e.g., singlet oxygen) or gen-
erate excited intermediates by reaction with phago-
cytosable components. The intermediates relax and,
in the process, emit photons. These photons can be
used for quantitative determination. Since the appli-
cation of 'native' chemiluminescence however, is
hampered by several technical problems (e.g., ex-
tremely low photon yield), high cell densities are
necessary. One additional problem is that the emit-
ted light stems from different reactions and therefore
has a broad energy spectrum (14, 15).
These analytical problems can be overcome by using
chemilumigenic Substrate probes (16, 17). One of
the most common .chemilumigenic Substrate probes
used to measure phagocytic activity is luminol (5-
amino-2,3-dihydrophthalazine-l,4-dione), which is
oxidized by reactive oxygen species via excited inter-
mediates to 3-aminophthalate. The transition of the
intermediates to the ground state is accompanied by
emission of light in a narrow frequency r nge
(425 nm) (18). The reactive oxygen compounds
formed during phagocytosis serve s the oxidizing
agent. The emitted photon yield can be increased by
a factor of approximately 1000 by the addition of
luminol. Therefore, only a small number of granulo-
cytes (approx. l O4) are needed for the test System.
The small samples of blood necessary for measure-
ment are advantageous, for example in newborns, or
patients with neutropenia where only a limited
number of granulocytes are available. In recent
years, varipus groups of researchers have used lu-
minol-enhanced chemiluminescence to measure the
functional activity of granulocytes (e.g., 19—22) or,
with constant granulocyte concentration and varia-
ble amounts of serum, the opsonic capacity of the
serum (19, 20, 23, 24). In such techniques, the gra-
nulocytes are isolated from the blood by different
Standard procedures (e.g., dextran Sedimentation,
Ficoll-Hypaque). Since many of these techniques are
time consuming, some researchers have attempted to
measure luminol-dependent chemiluminescence di-
rectly in whole blood samples, utilizing the ultrasen-
sitivity of this method. Some groups measured only
slightly diluted blood samples (end dilution, approx.
1:5); the results obtained with low diluti ns, howev-
er, are influenced by various cellular and molecular
components of whole blood (25-29). Other teams
used highly diluted blood samples (end dilution
1:20-1:5000) (30-32).
Experimental data on the measurernent of phagocy-
tosis-dependent chemiluminescence in whole sam-
ples under a variety of conditions are presented. Al-
though the advantages of this technique are clear
(i.e., no sample preparation, possibility of automati-
zation of test System), the results, particularly in
slightly diluted blood samples, are far from exact.
Procedures therefore were sought which would elim-
inate these disadvantages, but which would not re-
quire an overly time^consuming cell preparation. In
the first System, the querich effect was avoided by
erythrocyte lysis, a method which also ensures rapid
Isolation of the total leucocyte fraction. Finally pure
granulocytes were isolated with a modified Percoll
method.
Materials and Meihods
Chemicals and media:
Zymosan A: Sigma Munich/FRG; Luminol (5-amino-2,3-djhy-
dro-l,4-phthalazinedione), l mmol/1: Lumac, Basel/S witzerland;
PMA (4- -phorbol-12-myristate-13^acetate), Sigma, Munich/
FRG; PBS (phosphate-buffered saline + Ca++ + Mg++): Se-
romed, Munich/FRG; Dulbecco's modified Eagle's medium +
HEPES: Boehringer, Mannheim/FRG.
Preparation of opsonized zymosan
600 mg of zymosan were suspended in 60 ml of 9 g/l NaCl, stirred
overnight, and homogenized with a Pptter-Elvehjem apparatus.
After centrifugation (10 min, 2000 g), the zymosan was incubated
with freshly drawn serum (30 min, 37 °C). After a secpnd centrl·
fugation, the opsonized zymosan pellet was washed and res s-
pended in 12 ml of 9 g/l NaCl. The resulting Suspension was di-
vided into several 150 μΐ samples and stored at — 20 °C.
C h e m i l u m i n e s c e n c e assay v. -
Whole blood methods
I. The test System according to Kalo (26) was performed s fol-
lows:
100 μΐ blood (10 lU/rnl heparin) + 400 μΐ buffer (Dulbecco's
modified Eagle's medium + HEPES, pH 7.4; or PBS, pH 7.2) +
10 μΐ luminol (0.2 mmol/1) were incubated for 10 minutes at
37 °C. Thereafter, 10 μΐ zymosan (l mg) were added to the test
System.
II. The test Systems according to Allen (31, 32) were performed
s follows:
a) 100 μΐ EDTA blood were diluted with 900 μΐ PBS -h l g/l glu-
cose -f l g/l albumin. 100 μΐ of this dilution were iricubated with
1.7 ml PBS in the presence of 20 μΐ luminol (0.2 mmol/1) 10 min,
37 °C). Phagocytosis was started by adding 20 μΐ opsonized zymor
san (50 g/l).
b) In a second System, EDTA blood was diluted l: 100. 50 μΐ of
this dilution were incubated using the System described above.
Meihods using granulocyte preparations
III. Lysis of erythrocytes for the Isolation of leukocytes
250 μΐ of EDTA blood were incubated with 5 ml of ice-cold
NH4C1 solution (8.3 g/l NH4C1, 37 mg/1 Na? EDTA, lg/1
KHCO3) cfor 5 minutes. After centrifugation (5 min, 200 g), the
cells were washed once, resuspended in phosphate-buffered saline
(PBS, + Ig/l albumin + l g/l glucose), and adjusted to 3 x 10*
granulocytes per liter.
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Chemiluminescence test conditions
ΙΟΟμΙ of cell Suspension (3 X l O8 granulocytes per liter) plus
1700 μΐ phosphate buffered saline (PBS + l g/l albumin + l g/l
glucose) plus 20 μΐ of luminol (0.2 mmol/1) were preincubated for
10 minutes at 37 °C. The reaction was initiated by adding 20 μΐ of
opsonized zymosan (50 g/l).
Results
Method I
(Dilution of blood samples by approximately l: 5 ac-
cording to Kalo (26)).
IV. Preparation of purified granulocytes
The granulocytes were isolated with a modified procedure accord-
ing to Hjorth (33).
Preparation of Step gradients
12 polystyrcne tubes (capacity, 4 ml) were filled with l ml of ap-
proximately 70% Percoll-NaCl solution (nD20 « 1.3477; refrac-
tometer, Zeiss, Oberkochen/FRG). l ml of an approximately
55% Percoll-NaCl solution (nD20 = 1.3450) was layered over this
with a l ml syringe. The hydrostatic pressure of the Percoll solu-
tion ensured automatic preparation of the gradients. Parallel
preparation of 12 gradients therefore was possible within approxi-
mately 15 minutes. The gradients can be stored for l to 2 days in
the cold-storage room.
Isolation of granulocytes
500 μΐ of EDTA blood were applied to the gradients and centri-
fuged at 20 °C for 10 minutes (350 g). During this time, the eryth-
rocytes settled to the bottom and the granulocytes collected on the
boundary layer between the two density Steps, which were well
separated from the mononuclear fraction and the platelet-rich
plasma. After withdrawal of the supernatant layer, the granulo-
cyte zone was removed, suspended in 9 g/l NaCl, and washed
once (5 min, 350 g). The cells were resuspended in phosphate
buffered saune (PBS, + l g/l albumin + l g/1 glucose) and adjust-
ed to 3 x 108 granulocytes per liter (cell viability, 99% on trypan
blue test; leukocyte contamination, l%-2%). The erythrocyte:
granulocyte ratio was 0.2-0.5:1.
Under selected conditions, erythrocytes do not always settle to the
bottom, i.e., in approximately 15% to 20% of all investigated pa-
tients and 5% to 7% of all "healthy" individuals. In such cases,
there are two possible methods of correction: NHUCl lysis of the
erythrocyte-contaminated granulocyte Suspension (no effect on
Chemiluminescence measurements) and Separation of EDTA
blood in a parallel run via a second Percoll gradient of lower den-
sity (step l:nD20 = 1.3468; Step 2:nD20 = 1.3450). This second
method was finally used, providing additional Information about
the Sedimentation pattern of the blood cells.
Chemiluminescence test conditions
100 μΐ of the granulocyte Suspension plus 500 μΐ of phosphate
buffered saline (PBS + l g/l glucose + l g/l albumin) plus 50 μΐ
luminol (0.2 mmol/ϊ) were preincubated for 10 minutes at 37 °C.
The reaction was initiated by adding 20 μΐ opsonized zymosan
(50 g/l).
Other methods
Differential blood counting was carried out with Sangodiff
(Merck, Darmstadt/FRG).
Leukocytes were counted in an ai 134 cell counter (dilab, Karls-
ruhe/FRG).
Chemiluminescence assay was performed on a Biolumat (LB
9505; Berthold, Wildbad/FRG). The results were evaluated with
a model 43 teletype or an Apple II using the program "Bio".
Granulocytes, mononuclear fraction, and erythrocytes were isolat-
ed according to the Percoll method described by Hjorth (33).
Platelets were prepared by differential centrifugation s described
in I.e. (26).
Course of Chemiluminescence response
The Chemiluminescence curves of zymosan phagocy-
tosis reported by Kato extended over roughly a 40-
minute period. When the reaction is followed for a
longer period of time, a second peak appears after
approximately 120 minutes which, in the selected
test System, is somewhat higher than the first peak
(fig. 1). Figure l shows the course of the Chemilumi-
nescence response during zymosan phagocytosis; the
response was measured immediately after blood col-
lection and again after storage of the blood sample at
room temperature for 150 minutes. The results
showed a sharp increase of the first peak and a de-
crease in J:he second. The height of the first peak can
be taken s an indicator of phagocytic activity in re-
sponse to zymosan. The second peak is probably
caused by erythrophagocytosis (47).
20 40 60 ΘΟ
t i m i n ]
100 120 HO
Fig. l, Chemiluminescence response of whole blood samples
(1:5 dilution) in the phagocytosis of zymosan.
Points: Immediately after collection of blood.
Empty circles: After storage of blood for 150 minutes at
room temperature.
Quench effects caused by erythrocytes
The high erythrocyte concentration in the test sys-
tem led to marked quench effects. Since the availa-
ble measurement Instruments are ultrasensitive, the
problem is not the reduced photon yield per se, but
rather the different haematocrit values and granulo-
cyte-erythrocyte ratios of the blood samples. To
study this Situation (fig, 2), an experiment was car-
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Fig. 2. Effect of different erythrocyte concentrations on photon
yield fraction (compared to unquenched probes).
Empty circles: Actual value (quenched probe).
Dashed line: Theoretical value (unquenched probe).
ried out based on the linear dependency between the
height of the maximum and granulocyte density dur-
ing phagocytosis (see fig. 7). Different quantities of
whole blood (20—100 μΐ) were adjusted to a con-
stant test volume (520 μΐ). Το eliminate different op-
sonization effects, each test mixture contained the
same serum fraction. Assuming the theoretical ab-
sence of a quench effect, the photon yield should be
proportional to the quantity of added whole blood,
e.g. the photon yields from mixtures containing
20 μΐ, 40 μΐ and 100 μΐ whole blood should be in the
ratio 2:4:10. In reality, the smaller volumes of
whole blood gave relatively higher yields of photons.
The values obtained for the individual dilutions were
expressed in percent and compared to the theoretical
values. Blood from four different donors with ap-
proximately the same erythrocyte and granulocyte
numbers and ratios were assayed. In another set up,
EDTA blood was centrifuged, the plasma drawn off,
and the cells pellet resuspended in buffer to yield the
same volume. 20-100 μΐ of the blood cell Suspen-
sion was used, s described, for the test with opson-
ized zymosan s the phagocytosable particle. The re-
sults obtained in this test were practically the same
(data not given).
Effect of opsonization on chemiluminescence Signal
The contact between the phagocytosable zymosan
and the serum leads to opsonization of the zymosan
and therefore facilitates the uptake of zymosan by
the granulocytes. This fact is related to enhancement
of the chemiluminescence Signal. When all other pa-
rameters in the test System are held constant and on-
ly the serum is varied, the opsonic capacity should be
determinable with chemiluminescence. A more ex-
act evaluation of the serum, howeverj indicates the
presence of several other substances that have a
strong modulating effeet on the chemiluminescence
response (34, 35). The following experiinents were
carried out to eonfirm this Situation (fig. 3). The
quantity of serum and the type of zymosan opsoniza-
tion were varied in a Standard* test System (100 μΐ
granulocytes (3 Χ 1Ό8 cells per liter) + 50 μΐ luminol
(0.2 mmol/1); total volume after addition of serum
and PBS, 670 μΐ, pH 7.4), The maximum of the
chemiluminescence signal (counts/min) was used s
characteristic measurement p fameter.
3000
•l 2000 -
1000-
ε
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Fig. 3. Effect of serum on chemiluminescence response in phago-
cytosis of zymosan under different opsonization condi-
tions.
Triangles: Test a, external opsonization, removal of se-
rum.
Points: Test b, external opsonization without removal of
serum.
Open circles: Test c, direct incubation.
Test a
20 μΐ zymosan (50 g/l) were added to 0, 50, 100,
150, 200, .or 250 μ1· of fresh serum; PBS was added
to yield a volume of 500 μΐ, and the Suspension was
externally opsonized for 30 minutes at 37 °C. The
Suspension was then centrifuged, the excess serum
drawn off, and the opsonized zymosan resuspended
in buffer to yield a total volume of 500 μΐ. This sam-
ple was mixed with the granulocytes and chemilumi-
nescence measufed. » f
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Test b
The preparation was carried out in the same way s
described above, except that the entire Suspension
was used in the test System instead of centrifuging off
the serum after 30 minutes of opsonization.
Test c
In this test System, various amounts of serum (0—
250 μΐ) were directly incubated with the granulo-
cytes and the zymosan.
As figure 3 shows, concurrent effects are apparently
responsible for the formation of the chemilumines-
cence signal. Due to the opsonization of zymosan,
the chemiluminescence signal is increased by the
presence of serum in the test niixture. On the other
hand, serum causes a reduction of the photon yield
in the test System, s tests b and c clearly indicate.
The slight reduction of measured maxima (counts/
min) with increasing serum fraction in test a can
probably be attributed to residual "contamination"
of the serum after centrifugation (opsonized zymo-
san was not washed to avoid substance loss during
centrifugation).
Method Π
(Dilution of blood by approximately 1:200 or
1:4000 according to Allen (31, 32)).
Allen described two riiethods for measuring phago-
cytosis in whole blood using luminol s chemilumi-
genic Substrate probe:
1. Test system with blood dilution of 1:200 (32);
2. Test system with blood dilution of 1:4000 (31).
These high dilutions supposedly eliminate quench
effects. In contr st t the technique with l: 5 dilution
(Kato (26)) both these methods use opsonized zymo-
san; therefore only the cellular aspect of phagocy-
tosis is evaluated. Allen's st dies were carried out
with a test volume of 2000 μΐ (dilution of blood sam-
ples, l: 200) using a LSC. The results are not optimal
when these coriditions are transferred to the Biolu-
mat; reduction of test volume with all other parame-
ters held constant results in a significantly enhanced
chemiluminescence signal and earlier appearance of
the maxima (counts/min) (fig. 4).
Quench effects
To study whether quench effects also appear in this
test system, blood samples were used from the assay
with 1:4000 dilution according to Allen (test vo-
1500-
Fig. 4. Effect of test volume on chemiluminescence response of
blood (predilution, 1:10) in phagocytosis of opsonized
zymosan.
Test mixture: 100 μΐ EDTA blood (dilution, 1:10)
+ 50 μΐ luminol +
20 μΐ opsonized zymosan;
buffer added to yield different total volumes:
O O 1870 μΐ; X X 1270 μΐ;
Δ Δ 970 μΐ; D D 670 μΐ
lume, 2000 μΐ). The test was carried out according to
the same principle already described for the Kato
method (The actual photon yield was compared with
the theoretical values that would have been obtained
in the absence of quench effects). Table l shows the
results obtained using blood from four subjects with-
out consideration of the differing haematocrit, eryth-
rocyte, and granulocyte counts. As the table shows,
quench effects are also present; it should be noted
that the granulocyte-erythrocyte ratio in the test Sys-
tem is approximately 1:1000. The supposition that
the quench effect could possibly be eliminated by the
attachenaent of the granulocytes to the vessel wall of
the incubation vial (31) was not confirmed. Granulo-
cytes (3 X 104 cells) were incubated in an incubation
vial for 10 minutes at 37 °C. This sample was then
carefully transferred to second vial. The empty vial
with granulocytes, which may possibly attach to the
surface, was filled with fresh incubation buffer to
yield the original volume. Subsequent incubation of
Tab. 1. Studies of quench effect in highly diluted blood samples
Test
volume
(μΐ)
100
90
70
50
40
20
Theo-
retical
(%)
100
90
70
50
40
20
Sample
1
(%)
100
101
127
134
139
160
Sample
2
(%)
100
100
136
127
128
153
Sample
3
(%)
100
106
121
131
152
192
Sample
4
(%)
100
102
130
142
177
196
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both samples with opsonized zymosan showed only
approximately 15% of the chemiluminescence re-
corded for the first vial.
Effect ofdifferent zymosan concentrations on chemi-
luminescence signal
Figure 5 shows the effect of different zymosan con-
centrations on the height of the measured maximum
(counts/min). A good linear relationship was estab-
lished with 5 to 30 μΐ -opsonized zymosan per test
System (50 μΐ blood (prediluted 1:1000) H- 50 μΐ lu-
minol (0.2 mmol/Ί) + 500 μΐ phosphate buffered sa-
line).
In contrast to the quench effects where an exact cor-
rection is very difficult, correction of the signal does
appear to be possible in this case, even in probes
with widely varied granulocyte-zymosan ratios. The
appearance of the maximum, however, depends to
great extent on this ratio and therefore is not well
suited for use s a characteristic parameter.
20 40
t (mini
Fig. 6. Course of chemiluminescence response in phagocytosis of
zymosan (leukocyte preparation).
Hatching: Normal values (n = 14).
Points: Daily controls.
Triangles: Man with subcorneal pust losis.
Open cireles: Male psoriatic investigated on 3 eonsecu-
tive days (a, b, c).
2500-
42 2000
c.
l
S 1500
1000
500
12 7 (min)
0 5 10 15 20 25 30
Opsonized zymosan (μΐ]
Fig. 5. Dependence of measured maxima (counts/min) on quan-
tity of opsonized zymosan in temporal association with ap-
pearence of maximum (n = 3).
Method III
(Preparation of leukocytes after erythrocytes lysis
with NH4C1).
Course of chemiluminescence response
The course of chemiluminescence in the described
test System is shown in figure 6. The figure shows the
course of the chemiluminescence signal during pha-
gocytosis of opsonized zymosan in healthy persons;
s an example of clinical applic tion, the course of
the chemiluminescence signal is also shown in pa-
tients with common dermatplogical diseases (a man
with subcorneal pust losis, Sneddon-Wilkinson, and
a male psoriatic). Leukocytes from healthy subjects
served s controls on each day of the experiment.
The control values were in the r nge determined for
the normal group u$ing the saine opsonized zymosan
Charge; using the same ratio of cell density to opson-
ized zymosan, the values of tfee patients were
markedly higher than those of the controls. The dif-
ferent blood pictures were investigated prior to the
measurement of chemiluminescence so that the gra-
15 30 42
Grcmulpcytes HO3 per test]
51
Fig. 7. Dependent relationship between measured maxima
(counts/min) and number of granuio'cytes (0.6—6.0 x
l O4) in incubation with opsonized zymosan (20 μΐ).
J. CHn. Chem. Clin. Biochem. / Vol. 22, 1984 / No. l
Bruchelt and Schmidt: Chemiluminescence during phagocytosis
nulocyte number could be held constant in all test
assays and the time of the measured maximum
(counts/min) used äs a characteristic reaction pa-
rameter.
Linear dependencies exist between chemilumines-
cence maxima (20 opsonized zymosan; ränge, 0.6
- 6.0 x 104 cells/test) and cell density (fig. 7), äs
well äs between integrated counts and cell density.
Thus, variations in the granulocyte-opsonized zymo-
san ratio apparently do not affect the height of the
maximum, which remains linearly proportional to
cell density. The time at which the maximum ap-
pears, however, is influenced by alterations in gra-
nulocyte function.
Establishment of normal values and a few character-
istic data
14 healthy male and female subjects (age ränge,
20—40 years) were examined over a 3-week period.
The following values for the characteristic chemi-
luminescence phagocytosis parameter were estab-
lished with the opsonized zymosan Charge "1/82":
Measured maximum (counts/min):
Time of measured maximum:
Integrated counts after 60 minutes:
3031 ±657 x 103
20-26 minutes
13.8 ± 2.04 x 107
lysis medium or 5 ml saline solution (control). After
jncubation for 5 minutes, the cells were centrifuged,
washed, and adjusted to 3 x l O8 cells per liter. The
following values were obtained (n = 5; the NaCl
value was arbitrarily set at 100% in each pair of
values):
NaCl group NH4C1 group
Measured maximum 100% 102 ± 13%
Time of maximum 10-12 min 10-12 min
Integrated counts (60 min) 100% 98 ± 10%
Evaluation
The quench effect, one of the primary problems as-
sociated with whole blood methods, was successfuly
eliininated with this method. In addition, the differ-
ential blood picture was prepared prior to chemilum-
inescence measurement to ensure a constant granul-
ocyte concentration in the test System. Advance
preparatipn of the differential blood picture, howev-
er, presents technical problems when large numbers
of samples are to be evaluated. The Percoll method
according to Hjorth (33) for the Isolation of pure
granulocytes therefore was subsequently used and
modified so that suitable cells could be isolated for
Chemiluminescence measurement of phagocytosis
within a short period of time.
Precision
Measurement-to-measurement variations were ex-
amined in 6 identical tests run parallel in the 6 chan-
nels of the Biolumat (±4%).
Method IV
(Preparation of isolated granulocytes by the Percoll
method)
Effect of storage of EDTA blood at room temper a-
ture
Compared to measurements made directly after col-
lectipn of blood samples (100% value), values after
2-hour storage at room temperature were 112 ±
13% (n = 10). A 75% to 80% reduction in mea-
sured maxima was recorded in isolated cells that
were allowed to stand for l hour at 0 to 4 °C prior to
Chemiluminescence measurements.
Effect of NH&l on Chemiluminescence Signal
The following experiment was carried out to clarify
the effect of the lysis medium on the granulocytes.
The granulocytes were isolated with the Percoll
method, washed, and resuspended in physiolögic so-
lution. 250 samples of the granulocyte Suspension
(3 x l O8 cells per liter) were mixed with either 5 ml
Course of Chemiluminescence response
Characteristic curves and the method of documenta-
tion, using the " " program, are presented in fig-
ure 8: Duplicate assays are shown for 2 subjects us-
ing luminol äs chemilumigenic Substrate probe in
chaniiels l and 2 äs well äs 4 and 5; lucigenin (same
concentration äs luminol) was used äs chemilumi-
genic Substrate probe for the probes in channels 3
and 6 (subject l, patient with burns over 20% sur-
face: subject 2, control).
In order to establish a test System with good photon
yield, the following parameters were varied:
a) Determination of a favourable granulocyte-zymo-
san ratio
The course of the measured maximum with different
granulocyte densities dependent on the amount of
J. Clin. Ghem, Clin. Biochem. / Vol. 22,1984 / No. l
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Fig. 8. Documentation of Chemiluminescence measurement using
"ΒΙΟ" program with automatic scaling.
this interval was used s the characteristic measure-
ment parameter in all subsequent experiments.
b) Determination of suitable lest volume
Holding the other parameters (4 X 1 4 granulocytes,
50 μΐ luminol, 20 μΐ opsonized zymosan) constant,
the total test volume was varied by adding iiicreasing
amounts of b ffer:
Total test Chemiluminescence
volume maximum
(ul) (counts/min)
Time of Chemiluminescence
maximum
(min)
670 5211
1170 1901
1670 1056
12
24
31
Due to the measurement geometry of the Instrument
and the dilution of the f eaction partners, the photon
yield declines sharply s the test volume increases. A
total test volume of 670 μΐ was used in all subsequent
experiments.
opsonized zymosan is shown in figure 9 a. Based on
these data, an assay consisting of 20 μΐ of opsonized
zymosan (50 g/l) and 3 x 104 granulocytes was se-
lected for the Standard test System. The course of the
Integration curves for different granulocyte concen-
trations with 20 μΐ opsonized zymosan is presented
in figure 9b. In both cases, a linear relationship ex-
ists between the number of granulocytes and the
photon yield. Since, in all our experiments, the
chemiluminescence-detected reaction was terminat-
ed after 60 minutes, the Integration of the counts in
c) Determination of a favourable luminol concentra-
tion
The test System consisted of 100 μΐ of granulocytes
(3 x 104), 20 μΐ of opsonized zymosan, and varying
amounts of 0.2 mmol/1 luminol solution (20, 40, 60,
80, 100 μΐ), and buffer ad 670 μΐ. Α linear depend-
ency exists between the luminol concentration and
the photon yield in the investigated r nge (measured
maximum, 1920 counts/min (20 jjfl) to 7860 counts/
min (100 μΐ)). 50 μ] of luminol were used in the Stan-
dard test System.
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c
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Fig. 9 a. Relationship between measured maxima (counts/min) of
different granulocyte concentrations iiicubated with dif-
ferent amounts of opsonized zymosan.
-Δ5μ1; A Δ 10 μΐ; Ο Ο 20 ul:
-Ο 30 μΐ ^
Granulocytes HO3]
30
10 20 30 40
t [min)
60
Fig. 9b.0 Course of Chemiluminescence Integration e rves of dif-
ferent granulocyte concentrations incubated with 20 μΐ
opsonized zymosan (50 g/1).
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Determination of reference values
Granulocytes from 18 healthy men and women col-
lected over a period of 2 weeks were used for chemi-
luminescence measurement to determine the normal
values for the selected test conditions and for a de-
fined Charge of opsonized zymosan (in described
case, "2/82"). The blood specimens were collected
in the morning and in the afternoon. Evaluation of
blood specimens collected twice a day from 3 indi-
viduals indicated that the time of the blood collec-
tion had no effect on the Chemiluminescence signal.
The following characteristic Chemiluminescence pa-
rameters were established:
Mcasured maxima (counts/min): 5085 ± 634 x l O3
Timcof maximum (min): 8-11
Integration after 60 min: 15.1 ±2.1 108
Standard deviation of single measurement: ± 3.5%
EDTA blood can be stored for a few hours at room
temperature without any perceivable change in the
Chemiluminescence signal of the granulocytes: Re-
lated to the starting value for immediately processed
blood, the measured maxima (counts/min) after
storage of the blood for 150 minutes at room
temperature were 101 + 5% (n = 6). A slight loss of
activity was noted in isolated cells after 30 min stor-
age on ice (97 + 7%).
Effect of Percoll on Chemiluminescence signal
The effect of Percoll in the test System was studied in
the following experiments:
a) The granulocytes were isolated according to the
Percoll method to determine the direct effect of Per-
coll. Aliquots were applied directly in the Standard
test System: In one case, the Percoll solution was
centrifuged and the washing Step (removal of Percoll
from the cells) was omitted; in another case, the cells
were washed äs usual: The Chemiluminescence re-
sponse in the phagocytosis of opsonized zymosan
(measured maxima, 113 ± 10% compared to Stan-
dard System, n = 3) is slightly higher with Percoll in
the test System than in a Percoll-free granulocyte
preparation.
b) The leukocytes (3 x 104 granulocytes/test) were
isolated with method III (NH4C1 lysis) and incubated
with 20 of pure Percoll instead of opsonized zymo-
san. The photon yield obtained with the direct incu-
bation of Percoll under the selected conditions was
negligibly low.
c) The effect of Percoll was tested in another assay
äs follows: Leukocytes (isolated by method III) were
divided into two samples. 0.5 ml of one fraction (ap-
prox. 3 x 106 granulocytes corresponding approxi-
mately to the amount coming in contact with l ml of
55% Percoll solution during Percoll centrifugation)
was mixed with l ml 9 g/l NaCl solution; 0.5 ml of
the other fraction was mixed with l ml of a 55% Per-
coll solution, allowed to stand for 10 minutes at
room temperature, and then centrifuged. The cells
were washed and examined in the Standard test sys-
tem. The Chemiluminescence response of cells incu-
bated with Percoll was higher than of cells incubated
without Percoll: the measured maximum was 121 ±
8% (n = 3) compared to the control which was arbi-
trarily set at 100%.
Relationship between Chemiluminescence signal and
opsonized zymosan
Zymosan was opsonized with the serum of healthy
individuals, äs described in the section "Material and
Method$". The preparation was sufficient for ap-
proximately 500 determinations. Since the opsoniza-
tion capacity of each individual donor serum is dif-
ferent, a new normal control (n = 6—10) was always
prepared when opsonized zymosan charges were
changed. In the context of a test series, the obtained
Chemiluminescence values of the investigated pa-
tients were compared with those of each normal con-
trol group. In addition, granulocytes from a healthy
subject, the values of which agreed with those of the
normal group, served äs control on each test day.
The following experiments were carried out with op-
sonized zymosan:
a) Some fresh zymosan samples were frozen and
theirthawed; some were immediately used without
freezing for the Chemiluminescence test. No differ-
ences in the photon yield could be established be-
tween frozen und fresh zymosan samples.
b) For theoretical reasons, the effect of the storage
period on the quality of the zymosan cannot be pre-
cisely determined: no standardized granulocytes are
available. However, since Chemiluminescence re-
sponses for the same subject were very similar (max-
ima, 3476 ± 298 x l O3 counts/min) in 5 assays car-
ried out at one-week storage intervals over a period
of 5 weeks it is reasonable to assume that this storage
period does not negatively effect the quality of op-
sonized zymosan.
Example of a clinical application
Various granulocyte dysfunctions developing after
severe burn injuries have been detected with chemi-
J. Clin. Chem. Gin. Biochem. / Vol. 22,1984 / No. l
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luminescence methods (32, 43, 44). Our studies also
confirmed the observation that granulocyte dysfunc-
tions can be detected with Chemiluminescence meth-
ods: As an example, the courses of the measured
maxima (counts/min) for two patients who were ad-
mitted to hospital at the same time were followed for
several days (patient l, burns over 20% of total body
surface; patient 2, third degree burns over 50% of
total body surface) are shown in figure 10. Granulo-
cyte activity declined sharply within a few days in the
severely burned patient, who died on the sixth post-
burn day, but increased slightly within a few days in
the patient with burns over only 20% of the total
body surface.
One interesting finding was observed in the patient
with burns over 50% of the total body surface, after
he was given fresh frozen plasma (750 ml) on the
third postburn day. While granulocyte activity on
this day, prior to administration of fresh frozen plas-
ma, was already sharply diminished, the activity of
granulocytes isolated 5 hours after fresh frozen plas-
ma administration was even higher than that of nor-
mal individuals. It therefore is entirely possible that
the low granulocyte activity was conditioned by the
qualitatively inferior serum of the burn patient (pos-
sibly due to the absence of certain components or the
presence of toxic factors). This Situation therefore
l
i
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10. Changes in measured maxima (counts/min) for two burn
patients several days after the burn event.
F ll line: Man with burns over 50% of total body sur-
face.
Broken line: Man with burns over 20% pf total body
surface.
Hatched: maxima (counts/min) of daily controls.
was compensated by adding high quality serum. Gra-
nulocyte activity approximately 20 hours later was
again markedly diminished (half time of granulo-
cytes in blood, 6—7 hours (5).
In conclusion table 2 summarizes the characterized
feature of the four test Systems investigated.
Tab. 2. Comparison of 4 investigated methods with Chemiluminescence measurement during phagocytosis of zymosan.
Anticoagulants
Preparation of probes
I
Whole blood method
(dilution approx. 1:5)
Heparin, no EDTA
II
Whole blood method
(dilution approx. 1:4000)
EDTA etc.
III
Whole blood
lysedwithNH4Cl
EDTA etc.
35 min*)
IV
Granulocytes
(Percoll-method)
EDTA etc.
25min
Test System
Possible disturbances due to
serum
cell-cell interaction
quench effects
storageof blood
all blood cells +
plasma -h zymosan
all blood cells +
opsonized zymosan
(withdiff.
blood picture)
all leukocytes +
opsonized zymosan
granulocytes +
opsonized zymosan
wecessary procedures
Necessaty amount of blood (approx)
Granulocyte concentration per test
Zymosan-granulocyte ratio
measurement
diff. blood picture
correction
100 μΐ
variable
variable
measurement
diff. blood picture
correction
1-5 μΐ
variable
variable
measurement
lysis
diff. blood picture
200 ul
3 Χ ΙΟ4*)
constant*)
measurement
cell isolation
counting
500 μΐ ·«
3 x ΙΟ4
constant
*) when differential blood picture is prepared prior to Chemiluminescence measurement.
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Discussion
In recent years, Chemiluminescence measurements
have become increasingly important äs an analytical
method. Possible uses of this ultrasensitive method
include assessing many metabolites and enzymes,
monitorung functional activity of neutrophilic gra-
nulocytes, or measuring opsonic capacity of serum
(32). The introduction of chemilumigenic Substrate
probes made it possible to enhance the sensitivity of
the test System to such an extent that Chemilumines-
cence can be measured in whole blood. We also eval-
uated test Systems with slightly diluted blood sam-
ples and Systems with highly diluted samples. The
Problems discussed first are those arising in associa-
tion with Chemiluminescence measurement of slight-
ly diluted whole blood samples. The tests reported in
the present study are based primarily on the test sys-
tem introduced by Kato and coworkers (26).
The Chemiluminescence Signal obtained with this test
System is predominantly a function of granulocyte
density and activity äs well äs of the concentration of
serum components with opsonic capacity. Direct
utilization of the obtained Chemiluminescence signal
for characterization, however, is not possible. Since
granulocyte density can vary considerably from sam-
ple to sample, the measurement values must be re-
lated to a constant granulocyte count. Similary, the
serum must be corrected (i.e., opsonic concentra-
tion), depending on the haematocrit of the blood
sample. Even äfter these corrections have been
made, the Chemiluminescence signal is still difficult
to Interpret. An abnormal value provides no Infor-
mation about whether the abnormality is of a cellular
or hümoräl näture. Additional tests are necessary to
clarify this point. A value in the normal ränge also
does not provide absolutely reliable Information
about the functional state of the granulocytes or the
humoral Systems: a deficiency pf any one component
can elicit a partial and temporary compensation on
the pari of the other component, thus siniulating
normal conditions. Steven and coworkers (20), for
example, described a case of neutropenia with in-
creased granulocyte activity and depressed opsonic
capacity. The opsonization defect would probably
have gone undetected with a whole blood assay.
Finally, there are several other interfering factors in
this test System. The primary interference is the pro-
nounced quench effect produced by the erythro-
cytes; exact correctioas, however, pose a major
problem. The erythrocyte quenching of the Chemi-
luminescence in figure 2 is an idealistic Situation, be-
cause the tests were carried out using blood samples
with approximately the same erythrocyte-granulo-
cyte ratio. In practice, however, there is usually con-
, siderable Variation in the erythrocyte-granulocyte
ratios of the blood samples, a factor which addition-
ally complicates correction.
The Situation is impossibly complicated when all
possible factors that interfere with the Chemilumi-
nescence response are taken into consideration.
At the cellular level, mention should be made of the
contributions of platelets (36) and monocytes, and
the strong dependency between the Chemilumines-
cence signal and the storage period of the blood
(fig. 1), a dependency which should be attributed to
a granulocyte-platelet interaction in resting blood
(26). In addition to opsonization effects, humoral ef-
fects are also numerous and may be, in part, func-
tionally related to the phagocytosis process (e.g., the
effect of Ca++ ions) or may nonspecifically influence
the Chemiluminescence signal in the test System. Ex-
amples of this are the effect of the protein concentra-
tion in the test System (34); ceruloplasmin (35);
substances such äs Superoxide dismutase and cata-
lase, which are possibly released by erythrocytes
during incubation (37); chemotactic factors (38);
some amino acids (tryptophan, tyrosine, cysteine
(34)); and drugs such äs acetylosalicylic acid (39—
41). Even though many of these influences play an
insignificant role from a quantitative point of view,
the many possible interferences nevertheless impos-
sibly complicate the Situation. This test System there-
fore should only be used for questions in which
clearcut answers are to be expected, e.g., äs screen-
ing tests for severe genetically determined granulo-
cyte dysfunctions such äs occur in chronic granulo-
matous disease or for myeloperoxidase deficiency,
which elicits virtually no response in the luminol-en-
hanced Chemiluminescence test System.
Most of the problems mentioned here can be
avoided by the use of methods with highly diluted
whole blood: The experimental simplicity of the sys-
tem is preserved, the interfering effects of the serum
do not occur because of the high dilution, and the
Interpretation of the Chemiluminescence signal is
easier. A few problems, however, cannot be com-
pletely eliminated even in this System: Granulocyte
counts must still be corrected and the granulocyte-
opsonized zymosan ratio varies. This Variation in the
ratio interferes with the Chemiluminescence signal:
Under the selected test conditions, this interference,
however, does not effect the height of the measured
maximum, but it does influence the time at which the
maximum is reached (fig. 5). Finally, the quench ef-
fect by the erythrocytes cannot be entirely eliminat-
ed even in the highly diluted test Systems (approx.
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1:4000) using the Biolumat. The supposition that
most of the granulocytes attach to the vessel wall and
therefore escape the quench effect was not con-
firmed in our investigations.
The quench effect could possibly be further de-
pressed by a higher dilution of the test mixture (42).
The low granulocyte count, however, becomes a lim-
iting factor at dilutions exceeding 1:4000.
By way of summary, methods with highly diluted
whole blood are always preferable to methods with
lower dilutions, although these measurement meth-
ods are also problematic. We therefore attempted to
find other Systems which would eliminate these
problems; the requirements of such Systems are 1)
avoidance of the problems associated with whole
blood methods and 2) rapid Isolation of leukocytes.
In the first assay, these requirements were met in
whole blood samples by erythrocyte lysis. Under the
selected conditions, ihis procedure had no influence
on the quality of the granulocytes (see to the con-
trary, I.e. (46)). The quench effect was so effectively
eliminated that cells were available for the test with-
in approximately 15 minutes. For additional optimi-
zation, the differential blood picture was prepared
prior to the Chemiluminescence measurement so that
the same granulocyte density, and therefore a con-
stant granulocyte-zymosan ratio, were present in
each test assay. While this System ensures reproduci-
ble results, interactions can also be detected. The
slight rise in activity with EDTA blood stored at
room temperature would tend to indicate that such
interactions are actually present, even if only to a
slight degree. We also observed that when granulo-
cyte fractions isolated with the Percoll method and
mononuclear cells containing platelets are incubated
together, the Chemiluminescence response is always
15% to 20% higher than when both fractions are
incubated separately and their Chemiluminescence
Signals added together. The same effects described in
connection with the storage of whole blood may well
be responsible for this higher value (fig. 1).
A pure granulocyte fraction, on the other hand, can
be obtained by Separation of the cells via a Percoll
step gradient. Under these conditions, optimal stan-
dardization of the test System is possible: Only the
granulocytes and the phagocytosable particle are
present äs reaction partners. The modulating effects
of other substances on phagocytosis can be easily
tested by adding these substances tö the test assay.
Contrary to Hjorth's original instructions, the Isola-
tion volume was reduced since only small amounts of
granulocytes are required for the luminol-enhariced
System and NHUCI lysis is unnecessary. This then
means that cells with a grade of purity sufficient for
Chemiluminescence measurement (contamination by
only a few erythrocytes) are available for the test
System within approximately 25 minutes. The prepa-
ration of the Percoll gradiert ts is not time consuming;
parallel gradients can be performed rapidly withoüt
technical problems and the samples can be kept for
some time in the cold-storage room. The method is
also well suited for döcümentation, because, in con-
trast to most other methods, the graphic registration
of the Chemiluminescence course does not require
correction. Direct comparison of the samples there-
fore is possible. On the basis of the reasons cited in
the present study and our experienee with this and
other methods, we consider this procedure to be par-
ticularly well suited for obtäining clear, sensitive and
reproducible responses for oxidative processes oc-
curring during phagocytosis.
The followirtg two problems still need to be dis-
cussed:
1. The erythrocytes of some patients do not settle to
the bottom under the selected conditions. To pre-
vent this, a parallel run with a lower PercolJ density
was always carried out in patientWsäys*: As a result,
pure granulocyte preparations were obtained in all
investigated cases.
2. According to Hjorth, the Chemiluminescence re-
sponse of granulocytes isolated with the Percoll
method does not differ from that of granulocytes ob-
tained with the dextran method (33). Our studies,
however, indicated that Percoll is not entirely inert.
On the other hand, this effect should equally influ-
ence controls and test specimens.
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